TrialThe oncologist2017

Randomized Phase II Study of Ramucirumab or Icrucumab in Combination with Capecitabine in Patients with Previously Treated Locally Advanced or Metastatic Breast Cancer.

Linda T Vahdat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.